1030 related articles for article (PubMed ID: 15545678)
21. [The CONSORT statement (CONsolidated Standards Of Reporting Trials)].
Lorette G; Maruani A
Ann Dermatol Venereol; 2013; 140(6-7):431-5. PubMed ID: 23773740
[TBL] [Abstract][Full Text] [Related]
22. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.
Moher D; Schulz KF; Altman D;
Explore (NY); 2005 Jan; 1(1):40-5. PubMed ID: 16791967
[TBL] [Abstract][Full Text] [Related]
23. Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine.
Liu XT; Zhang X; Wen S; Peng L; Hong Q; Kang D
J Evid Based Med; 2015 Nov; 8(4):192-208. PubMed ID: 26334556
[TBL] [Abstract][Full Text] [Related]
24. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.
Moher D; Schulz KF; Altman DG;
BMC Med Res Methodol; 2001; 1():2. PubMed ID: 11336663
[TBL] [Abstract][Full Text] [Related]
25. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
Junqueira DR; Zorzela L; Golder S; Loke Y; Gagnier JJ; Julious SA; Li T; Mayo-Wilson E; Pham B; Phillips R; Santaguida P; Scherer RW; Gøtzsche PC; Moher D; Ioannidis JPA; Vohra S;
J Clin Epidemiol; 2023 Jun; 158():149-165. PubMed ID: 37100738
[TBL] [Abstract][Full Text] [Related]
26. Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement.
Rikos D; Dardiotis E; Tsivgoulis G; Zintzaras E; Hadjigeorgiou GM
Mult Scler Relat Disord; 2016 Sep; 9():135-9. PubMed ID: 27645361
[TBL] [Abstract][Full Text] [Related]
27. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.
Moher D; Jones A; Lepage L;
JAMA; 2001 Apr; 285(15):1992-5. PubMed ID: 11308436
[TBL] [Abstract][Full Text] [Related]
28. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
Ann Intern Med; 2006 Mar; 144(5):364-7. PubMed ID: 16520478
[TBL] [Abstract][Full Text] [Related]
29. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement.
O'Connor AM; Sargeant JM; Gardner IA; Dickson JS; Torrence ME; ; Dewey CE; Dohoo IR; Evans RB; Gray JT; Greiner M; Keefe G; Lefebvre SL; Morley PS; Ramirez A; Sischo W; Smith DR; Snedeker K; Sofos J; Ward MP; Wills R
Zoonoses Public Health; 2010 Mar; 57(2):95-104. PubMed ID: 20070653
[TBL] [Abstract][Full Text] [Related]
30. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
[TBL] [Abstract][Full Text] [Related]
31. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
[TBL] [Abstract][Full Text] [Related]
32. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist.
Devereaux PJ; Manns BJ; Ghali WA; Quan H; Guyatt GH
Control Clin Trials; 2002 Aug; 23(4):380-8. PubMed ID: 12161081
[TBL] [Abstract][Full Text] [Related]
33. The REFLECT statement: reporting guidelines for randomized controlled trials in livestock and food safety: explanation and elaboration.
Sargeant JM; O'Connor AM; Gardner IA; Dickson JS; Torrence ME; Dohoo IR; Lefebvre SL; Morley PS; Ramirez A; Snedeker K
J Food Prot; 2010 Mar; 73(3):579-603. PubMed ID: 20202349
[TBL] [Abstract][Full Text] [Related]
34. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
Moher D; Schulz KF; Altman DG;
Clin Oral Investig; 2003 Mar; 7(1):2-7. PubMed ID: 12673431
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the quality of reporting of randomised controlled trials in otorhinolaryngologic literature - adherence to the CONSORT statement.
Peters JP; Hooft L; Grolman W; Stegeman I
PLoS One; 2015; 10(3):e0122328. PubMed ID: 25793517
[TBL] [Abstract][Full Text] [Related]
36. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.
Grant S; Mayo-Wilson E; Montgomery P; Macdonald G; Michie S; Hopewell S; Moher D;
Trials; 2018 Jul; 19(1):406. PubMed ID: 30060763
[TBL] [Abstract][Full Text] [Related]
37. Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review.
Hadi MA; McHugh GA; Conaghan PG
Evid Based Med; 2017 Oct; 22(5):170-177. PubMed ID: 28866634
[TBL] [Abstract][Full Text] [Related]
38. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
Moher D; Schulz KF; Altman DG;
Ann Intern Med; 2001 Apr; 134(8):657-62. PubMed ID: 11304106
[TBL] [Abstract][Full Text] [Related]
39. Information on adverse events in randomised clinical trials assessing drug interventions published in four medical journals with high impact factors.
Maggi CB; Griebeler IH; Dal Pizzol Tda S
Int J Risk Saf Med; 2014; 26(1):9-22. PubMed ID: 24796347
[TBL] [Abstract][Full Text] [Related]
40. Has the quality of abstracts for randomised controlled trials improved since the release of Consolidated Standards of Reporting Trial guideline for abstract reporting? A survey of four high-profile anaesthesia journals.
Can OS; Yilmaz AA; Hasdogan M; Alkaya F; Turhan SC; Can MF; Alanoglu Z
Eur J Anaesthesiol; 2011 Jul; 28(7):485-92. PubMed ID: 21037480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
